Clinical trials
Terminated Phase 1/2 trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Menarini Group | 1 |
| Octapharma | 1 |
| Pfizer | 1 |
| Ultragenyx Pharmaceutical Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Blood Coagulation Disorders | 1 |
| Blood Coagulation Disorders, Inherited | 1 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Cholangiocarcinoma | 1 |
| Coagulation Protein Disorders | 1 |
| Fallopian Tube Neoplasms | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.